Georgia Stevens
Psychiatric/Mental Health, Adult · Washington, DCNPI 1255453478
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $426,640 of the $599,576 with a category attached, or 71.2%. Otsuka America Pharmaceutical, Inc. accounts for 81.7% of it on its own, with 11 other manufacturers making up the rest.
Across 731 payments — averaging $820.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$490K
- Vanda Pharmaceuticals Inc.$42K
- Alkermes, Inc.$26K
- Johnson & Johnson$19K
- Teva Pharmaceuticals USA, Inc.$8K
- Boehringer Ingelheim$6K
- plus $8K from 6 others
What the payments were for
- Consulting fees$66,64711%
- Speaking & faculty fees$426,64071%
- Travel & lodging$92,49815%
- Food & beverage$13,7562%
- Education$360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 581 | $489,938 |
| Vanda Pharmaceuticals Inc. | 47 | $42,180 |
| Alkermes, Inc. | 37 | $26,312 |
| Johnson & Johnson | 31 | $19,164 |
| Teva Pharmaceuticals USA, Inc. | 10 | $7,673 |
| Boehringer Ingelheim | 14 | $6,472 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $2,725 |
| H. Lundbeck A S | 1 | $2,000 |
| Lundbeck LLC | 3 | $1,858 |
| Axsome Therapeutics, Inc. | 1 | $1,138 |
| UCB, Inc. | 1 | $65 |
| Jazz Pharmaceuticals Inc. | 1 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$395,149
- ABILIFY MAINTENA$91,721
- ARISTADA$85,413
- ABILIFY ASIMTUFII$42,281
- Fanapt$41,482
- ARISTADA INITIO$20,159
- LYBALVI$19,194
- INVEGA SUSTENNA$18,755
- INVEGA TRINZA$18,618
- UZEDY$4,995
- AUSTEDO$2,085
- VYEPTI$1,749
- Auvelity$1,138
- INVEGA$127
How this compares
Too few psychiatric/mental health, adult providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sertraline Hcl | 11 | $367 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health, adult in Washington
- Alice BrittWashington$575
- Bridget NtungwenWashington$493
- Mary VandyWashington$140
- Susan SabadashWashington$115
- Maureen AbehWashington$114
- Jacqueline HuntWashington$28
- Tina JeffersonWashington$26
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.